4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001209191-22-002849
General Counsel sold 1,200 shares at $27.14 ($32,568)
- General Counsel acquired 1,200 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ring Christine General Counsel | 2022-01-10 | Option exercise | +1,200 | $1.86 | $2,232 | 2,486 | D: show line 1 in the form |
| Ring Christine General Counsel | 2022-01-10 | Sale | −1,200 | $27.14 | $32,568 | 1,286 | D: show line 2 in the form |
| Open-market sales · 1,200 sh · avg $27.14 · $32,568 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Ring Christine General Counsel | 2022-01-10 | Option exercise · Employee Stock Option (right to buy) | −1,200 | 100,066 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…